A Ocura Pharmaceutical Overview

  • Year Founded
  • 2017

Year Founded

  • Status
  • Private

  • Employees
  • 1

Employees

  • Latest Deal Type
  • Series A

  • Latest Deal Amount
  • $13.9M

  • Investors
  • 2

A Ocura Pharmaceutical General Information

Description

Developer of antisense oligonucleotide drugs intended for pharmaceutical markets and clinical institutions. The company's drugs focus on RNA splicing and RNA editing to treat spinocerebellar ataxia, enabling patients suffering from neuromuscular and spinal diseases to receive effective treatment and drug therapies.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Room 701, Building 15
  • Number 188 Kaiyuan Avenue, Huangpu District
  • Guangzhou, Guangdong 510000
  • China
+86 025
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Pharmaceuticals
Corporate Office
  • Room 701, Building 15
  • Number 188 Kaiyuan Avenue, Huangpu District
  • Guangzhou, Guangdong 510000
  • China
+86 025

A Ocura Pharmaceutical Timeline

2023202420252026
Financing Round

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

A Ocura Pharmaceutical Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Later Stage VC (Series A) 01-Jul-2024 $13.9M Completed Clinical Trials - General
2. Later Stage VC 11-Jul-2023 Completed Clinical Trials - General
1. Later Stage VC 22-Dec-2022 $4.26M $4.26M Completed Clinical Trials - General
To view A Ocura Pharmaceutical’s complete valuation and funding history, request access »

A Ocura Pharmaceutical Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

A Ocura Pharmaceutical Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds
State Development and Investment Group Government Minority
Herui Venture Capital Growth/Expansion Minority
To view A Ocura Pharmaceutical’s complete investors history, request access »

A Ocura Pharmaceutical FAQs

  • When was A Ocura Pharmaceutical founded?

    A Ocura Pharmaceutical was founded in 2017.

  • Where is A Ocura Pharmaceutical headquartered?

    A Ocura Pharmaceutical is headquartered in Guangzhou, China.

  • What is the size of A Ocura Pharmaceutical?

    A Ocura Pharmaceutical has 1 total employees.

  • What industry is A Ocura Pharmaceutical in?

    A Ocura Pharmaceutical’s primary industry is Drug Discovery.

  • Is A Ocura Pharmaceutical a private or public company?

    A Ocura Pharmaceutical is a Private company.

  • What is A Ocura Pharmaceutical’s current revenue?

    The current revenue for A Ocura Pharmaceutical is .

  • How much funding has A Ocura Pharmaceutical raised over time?

    A Ocura Pharmaceutical has raised $21.8M.

  • Who are A Ocura Pharmaceutical’s investors?

    State Development and Investment Group and Herui Venture Capital have invested in A Ocura Pharmaceutical.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process